CME on-demand webinar presented by ASHA | A comprehensive guide for the detection and management of the often neglected sexually transmitted infection, Trichomoniasis.
As we move into the post-public health emergency landscape with the expiration of the national emergency concerning the coronavirus disease 2019 (COVID-19) pandemic on May 11, 2023, it is essential to understand how the healthcare industry has adapted and evolved to address the unique challenges posed by the COVID-19 pandemic.
Visby Medical™ announced today that it has received 510(k) clearance and was granted a CLIA waiver from the FDA for its 2nd generation point of care (POC) test.
Visby Medical announced today that it has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration for its Respiratory Health point of care test.
Visby will be exhibiting at Emergency Nursing 2022 (ENA), a premier professional nursing conference dedicated to defining the future of emergency nursing through advocacy, education, research, innovation, leadership, and more.
Patients can now get results from PCR tests the same day thanks to new testing choices like Visby.
Join Visby Medical at ACEP 2022, an educational and networking conference hosted by the American College of Emergency Physicians.
Come see Visby Medical at the 28th AACC International CPOCT Symposium, a gathering designed to meet the needs of laboratory professionals.
Visby Medical will exhibit at the 14th Annual ConvUrgent Care Symposium. Since 2008, this conference has gathered healthcare leaders into a community around the increasing consumerization of medical care.
Trichomoniasis, commonly known as “trich,” is one of the most common sexually transmitted infections (STIs). It is caused by a one-celled parasite, Trichomonas vaginalis. Men and women are affected by this infection, but it occurs more often in women.